Aldeyra Therapeutics(ALDX)

当期报告

Aldeyra Therapeutics(ALDX)04-25 19:05

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001213900-24-035953  Act: 34  Size: 20 MB 网页链接查看全文

持股变动声明「修正」

Aldeyra Therapeutics(ALDX)04-18 04:15

$Aldeyra Therapeutics(ALDX)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-045108  Size: 6 KB 网页链接查看全文

当期报告

Aldeyra Therapeutics(ALDX)06-20 19:05

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-24-054003  Act: 34  Size: 4 MB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069887  Size: 7 KB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069885  Size: 10 KB 网页链接查看全文

当期报告

Aldeyra Therapeutics(ALDX)06-13 19:05

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-24-052234  Act: 34  Size: 219 KB 网页链接查看全文

其他

Aldeyra Therapeutics(ALDX)04-23 04:25

$Aldeyra Therapeutics(ALDX)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-104887  Act: 34  Size: 1 MB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069888  Size: 7 KB 网页链接查看全文

生效批准

Aldeyra Therapeutics(ALDX)04-25 18:05

$Aldeyra Therapeutics(ALDX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001104  Act: 33  Size: 1 KB 网页链接查看全文

持股变动声明

Aldeyra Therapeutics(ALDX)06-07 04:15

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069890  Size: 10 KB 网页链接查看全文

usbiostock2018-05-02 00:31

$Aldeyra Therapeutics, Inc.(ALDX)$ 在视觉和眼科研究协会2018年年会上公布干眼病2a期临床试验结果。数据显示， 0.1% Reproxalap局部用药可显著改善干眼病大部分症状。安全性和耐受性方面与标准治疗相当。查看全文

极光5222017-11-28 09:01

$Aldeyra Therapeutics, Inc.(ALDX)$ 果然我卖完就涨了查看全文

极光5222017-10-25 22:21

$Aldeyra Therapeutics, Inc.(ALDX)$ 冲动是魔鬼查看全文

Guoran2017-10-13 08:49

$Aldeyra Therapeutics, Inc.(ALDX)$ //@Guoran:ADX-102的2期临床实验报告。最新的13F表格10月10日显示二季度加仓的FMR LLC大概在数据公布后减去了其增加的仓位，但仍然保留了绝大部分仓位。目前持股1，611，311，占流通市值的8%。查看全文

波音助推道指收涨 凤凰新媒体领涨中概

大师来炒股2017-09-15 10:39

全球市场概览
中概股涨跌幅榜
点评
美股涨跌不一 波音助推道指上涨
美股周四涨跌互现，惟道指录得0.2%升幅。标普500指数11大板块6涨5跌，公用事业板块领涨，非日常消费品板块领跌。纽交所主板RASC领涨，GKOS领跌；纳斯达克HALO领涨，ARWR领跌。
点评：
美股隔夜低开，但受...查看全文

干眼症和Aldeyra Therapeutics

淘沙见金2017-09-15 00:15

相信各位经常在电脑前面的雪友有时候会觉得眼睛很干，这个问题也一直困扰着作者。作者上个月去做眼睛检查的时候跟眼科医生说了一下这个问题，医生检查了一下发现作者确实有轻度的干眼症。主要原因是长时间面对着电脑手机屏幕，缺乏适时地眨眼或让眼睛休息，影响了双眼的泪液分泌，进而导致泪腺发炎...查看全文

淘沙见金2017-09-12 18:50

$Aldeyra Therapeutics, Inc.(ALDX)$ Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) announced it will hold a webcast and conference call on Tuesday, September 12, 2017 at 8:00 a.m. EDT to provide the results from its dry eye disease Phase 2a clinical trial. Dry Eye disease represent...查看全文

hqy92017-06-16 03:10

$Aldeyra Therapeutics(ALDX)$ Aldeyra’s eye drug misses primary endpoint in phase 2查看全文

Aldeyra Therapeutics(ALDX.US)RASP抑制剂上市申请获FDA接受

智通财经APP获悉，2月7日，Aldeyra Therapeutics(ALDX.US)宣布FDA已接受其在研眼药水Reproxalap治疗干眼症的新药申请。FDA预计在2023年11月23日前完成审查。据悉，Reproxalap是一种潜在首创小分子促炎性活性醛类物质(RASP)抑制剂，能降... 网页链接

当期报告

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-24-054003  Act: 34  Size: 4 MB 网页链接

当期报告

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001213900-24-052234  Act: 34  Size: 219 KB 网页链接

当期报告

$Aldeyra Therapeutics(ALDX)$ 8-K Current report, item 5.07 Accession Number: 0001193125-24-157328  Act: 34  Size: 154 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069900  Size: 10 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069874  Size: 10 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069885  Size: 10 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069887  Size: 7 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069888  Size: 7 KB 网页链接

持股变动声明

$Aldeyra Therapeutics(ALDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-069890  Size: 10 KB 网页链接

季度财报

$Aldeyra Therapeutics(ALDX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-052056  Act: 34  Size: 6 MB 网页链接